The Study to Evaluate the effect of Encorafenib taken with cetuximab with or without Chemotherapy for the treatment of Mutant Colorectal Cancer
Study Title:
An open – label, Multicenter, Randomized Phase 3 study of First – line Encorafenib Plus Cetuximab With or Without Chemotherapy versus Standard of Care Therapy with a Safety Lead – in of Encorafenib and Cetuximab Plus chemotherapy in Participants with Metastatic BRAF V600E Mutant Colorectal Cancer.
Age From 16.00 Year (s) – 99.00 Year (s), Male or Female
Clinical Trail sites at : Delhi, Jaipur, Mumbai, Pune.
For more details Contact respective Principal Investigators mentioned in the CTRI Website
Copy and Paste the Below Link to your browser CTRI website URL for more details
http://ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=57794&EncHid=&userName=
